Realtime | Geld | Brief | Zeit |
---|---|---|---|
0,422 | 0,560 | 23.12. |
Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
06.12. | ORBUSNEICH (06929): POLL RESULTS OF THE EXTRAORDINARY GENERAL MEETING HELD ON DECEMBER 6, 2024 | 1 | HKEx | ||
18.11. | ORBUSNEICH (06929): FORM OF PROXY FOR USE AT THE EXTRAORDINARY GENERAL MEETING TO BE HELD ON DECEMBER 6, 2024 | - | HKEx | ||
18.11. | ORBUSNEICH (06929): NOTICE OF EXTRAORDINARY GENERAL MEETING | - | HKEx | ||
18.11. | ORBUSNEICH (06929): (1) PROPOSED REVOCATION OF THE EXISTING GENERAL MANDATES AND GRANT OF THE NEW GENERAL MANDATES; AND (2) NOTICE OF EXTRAORDINARY GENERAL ... | - | HKEx | ||
15.11. | ORBUSNEICH (06929): PROPOSED REVOCATION OF EXISTING GENERAL MANDATES AND GRANT OF NEW GENERAL MANDATES | 2 | HKEx | ||
ORBUSNEICH MEDICAL GROUP Aktie jetzt für 0€ handeln | |||||
25.09. | OrbusNeich Medical Group Holdings Limited: OrbusNeich Launches a High-Capacity Logistics Center in the Netherlands | 196 | PR Newswire | HOEVELAKEN, The Netherlands, Sept. 25, 2024 /PRNewswire/ -- OrbusNeich Medical Group Holdings Limited ("OrbusNeich" or the "Group"; stock code: 6929), a major global medical device manufacturer... ► Artikel lesen | |
11.09. | ORBUSNEICH (06929): INTERIM REPORT 2024 | 1 | HKEx | ||
16.08. | OrbusNeich Medical Group Holdings Limited: OrbusNeich Records Net Profit of US$18.8 Million for the First Half of 2024 | 360 | JCN Newswire | - Robust R&D Pipeline Drives Continued Commercial Progress- Efficient Integration of Acquired Assets Supports Long-Term Growth TrajectoryHONG KONG, Aug 16, 2024 - (ACN Newswire) - Results Highlights:-... ► Artikel lesen | |
16.08. | ORBUSNEICH (06929): ANNOUNCEMENT OF INTERIM RESULTS FOR THE SIX MONTHS ENDED JUNE 30, 2024 | - | HKEx | ||
06.08. | ORBUSNEICH (06929): DATE OF BOARD MEETING | - | HKEx | ||
31.07. | ORBUSNEICH (06929): PROFIT WARNING | 1 | HKEx | ||
10.06. | XFRA CAPITAL ADJUSTMENT INFORMATION - 10.06.2024 | 1.241 | Xetra Newsboard | Das Instrument D7G NO0010081235 NEL ASA NK-,20 EQUITY wird ex Kapitalmassnahme gehandelt am 10.06.2024 The instrument D7G NO0010081235 NEL ASA NK-,20 EQUITY is traded ex capital adjustment on 10.06.2024Das... ► Artikel lesen |
Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten |
---|